ApoC-III gene expression is sharply increased during adipogenesis and is augmented by retinoid X receptor (RXR) agonists

FEBS Lett. 2009 Jan 22;583(2):493-7. doi: 10.1016/j.febslet.2008.12.050. Epub 2008 Dec 31.

Abstract

ApoC-III, a lipoprotein lipase inhibitor and a key regulator of the metabolism of triglyceride-rich lipoproteins, is mainly synthesized in liver and intestine, but little is known about its expression in adipocytes. We here show that apoC-III mRNA levels are dramatically induced during adipocyte differentiation. Among many transcriptional factors involved in adipocyte differentiation, RXRalpha, acting alone and not as a heterodimer partner of other nuclear receptors, solely regulates apoC-III gene expression. These results suggest that apoC-III may play a specific role in lipid storage and mobilization in adipocytes, non-lipoprotein-secreting cells, and indicate the functional role of RXRalpha during adipocyte differentiation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipocytes / metabolism*
  • Adipogenesis / drug effects
  • Adipogenesis / genetics*
  • Animals
  • Apolipoprotein C-III / genetics*
  • Chromatin Immunoprecipitation
  • Gene Expression / drug effects
  • Gene Expression Regulation*
  • Mice
  • Retinoid X Receptor alpha / agonists
  • Retinoid X Receptor alpha / metabolism*

Substances

  • Apolipoprotein C-III
  • Retinoid X Receptor alpha